Coeliac disease vaccine trial underway

Proof-of-concept study will determine if the therapy can prevent the need for a gluten-free diet

An international trial is underway to test a vaccine that will potentially end the need for patients with coeliac disease to adhere to gluten-free diets.

The Australian arm of the phase 2 trial of the peptide-based immunomodulatory vaccine therapy will be conducted in Melbourne, Perth, Adelaide and Brisbane.